The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis
NCT ID: NCT01195519
Last Updated: 2011-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
95 participants
OBSERVATIONAL
2010-09-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Impact of Dialysis Treatment Type on Patient Survival
NCT00510549
Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China
NCT01413074
Improving Outcomes in Peritoneal Dialysis
NCT02207751
Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China
NCT02378350
A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform
NCT03571451
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
peritoneal dialysis and hemodialysis patients
peritoneal dialysis and hemodialysis patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* conscious clear and no psychosis
* literate and can communicate
* willing to participate and sign informed consent
Exclusion Criteria
* subject felt weak or uncomfortable and patients decision to withdraw from the study
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University WanFang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nephrology Dean
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tso-Hsiao Chen
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University WanFang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University WanFang Hospital
Taipei, No.111, Section 3, Hsing-Long Rd, Taipei, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Click here for more information about this study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
99039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.